Current status of liver transplantation in children

被引:54
作者
McDiarmid, SV [1 ]
机构
[1] Univ Calif Los Angeles, Med Ctr, David Geffen Sch Med, Div Gastroenterol Hepatol & Nutr, Los Angeles, CA 90095 USA
关键词
D O I
10.1016/S0031-3955(03)00150-0
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Remarkable short-term successes in providing transplants for thousands of children with liver failure have brought challenges into sharp focus. Clinicians must seek to move the life-giving science of transplantation toward a new goal: providing long lifetimes of excellent graft function with minimal toxicity from immunosupressive drugs and the hope of freedom from immunosuppression altogether. Pediatric liver recipients, whose grafts may have inherent tolerogenic potential and for whom we can anticipate decades of life after transplant, may prove to be an ideal study population to further these goals.
引用
收藏
页码:1335 / +
页数:41
相关论文
共 266 条
[81]   Portal venoplasty for recipients in living-related liver transplantation [J].
Harihara, Y ;
Makuuchi, M ;
Kawarasaki, H ;
Takayama, T ;
Kubota, K ;
Hirata, M ;
Kita, Y ;
Kusaka, K ;
Sano, K ;
Hashizume, K .
TRANSPLANTATION, 1999, 68 (08) :1199-1200
[82]   PREVENTION OF HEPATIC-ARTERY THROMBOSIS IN PEDIATRIC LIVER-TRANSPLANTATION [J].
HASHIKURA, Y ;
KAWASAKI, S ;
OKUMURA, N ;
ISHIKAWA, S ;
MATSUNAMI, H ;
IKEGAMI, T ;
NAKAZAWA, Y ;
MAKUUCHI, M .
TRANSPLANTATION, 1995, 60 (10) :1109-1112
[83]   Single-dose induction with daclizumab immediately after liver transplantation in pediatric patients [J].
Heffron, TG ;
Pillen, T ;
Smallwood, GA ;
Martinez, E ;
de Vera, ME ;
Romero, R .
TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) :1449-1449
[84]  
HERNANDEZ E, 2000, PEDIATR TRANSPLANT, V4, P152
[85]   Autoimmune hepatitis as a late complication of liver transplantation [J].
Hernandez, HM ;
Kovarik, P ;
Whitington, PF ;
Alonso, EM .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2001, 32 (02) :131-136
[86]   Adoptive cellular immunotherapy for EBV lymphoproliferative diseases [J].
Heslop, HE ;
Rooney, CM .
IMMUNOLOGICAL REVIEWS, 1997, 157 :217-222
[87]   THE FREQUENCY OF EPSTEIN-BARR VIRUS-INFECTION AND ASSOCIATED LYMPHOPROLIFERATIVE SYNDROME AFTER TRANSPLANTATION AND ITS MANIFESTATIONS IN CHILDREN [J].
HO, M ;
JAFFE, R ;
MILLER, G ;
BREINIG, MK ;
DUMMER, JS ;
MAKOWKA, L ;
ATCHISON, RW ;
KARRER, F ;
NALESNIK, MA ;
STARZL, TE .
TRANSPLANTATION, 1988, 45 (04) :719-727
[88]   Response of elevated Epstein-Barr virus DNA levels to therapeutic changes in pediatric liver transplant patients: 56-month follow up and outcome [J].
Holmes, RD ;
Orban-Eller, K ;
Karrer, FR ;
Rowe, DT ;
Narkewicz, MR ;
Sokol, RJ .
TRANSPLANTATION, 2002, 74 (03) :367-372
[89]   Persistent Epstein-Barr virus infection: Unrestricted latent and lytic viral gene expression in healthy immunosuppressed transplant recipients [J].
Hopwood, PA ;
Brooks, L ;
Parratt, R ;
Hunt, BJ ;
Maria, B ;
Alero, TJ ;
Magdi, Y ;
Crawford, DH .
TRANSPLANTATION, 2002, 74 (02) :194-202
[90]   Liver transplantation for hepatocellular carcinoma in patients without underlying liver disease: A systematic review [J].
Houben, KW ;
McCall, JL .
LIVER TRANSPLANTATION AND SURGERY, 1999, 5 (02) :91-95